Literature DB >> 23879080

[Food intake during the month of Ramadan in Moroccan patients with type 2 diabetes].

M Sebbani1, N El Ansari, G El Mghari, M Amine.   

Abstract

This cross-sectional study aimed to assess the daily dietary intake of type 2 diabetes patients attending Mohamed VI hospital in Marrakech during Ramadan 2010. Sociodemographic and clinical data were collected by interview, and qualitative and quantitative food intake, based on French nutritional tables, was assessed by a dietician. Of the 71 patients recruited, 55% were fasting. The average age of participants was 56.3 (SD 11,2) years. There were no statistically significant clinical differences between the fasting and nonfasting groups except for overweight/obesity and insulin dependence, which were more prevalent in the nonfasting group. The mean total daily caloric intake was significantly lower in the fasting than nonfasting group [1447.5 (SD 756.3) versus 1919.0 (SD 823.4) Kcal/d], as was the carbohydrate, lipid and protein intake. Carbohydrate intake was 57% and 56% of total calories. Overall during Ramadan the diet of the fasting group was calorie deficient and inadequate while for non-fasters it was excessive, which put them at risk of complications. Nutritional education may be needed for diabetic patients for Ramadan.

Entities:  

Mesh:

Year:  2013        PMID: 23879080

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  3 in total

1.  Food Expenditure and Food Consumption before and during Ramadan in Moroccan Households.

Authors:  Imane Barakat; Hamid Chamlal; Sanaa El Jamal; Mohammed Elayachi; Rekia Belahsen
Journal:  J Nutr Metab       Date:  2020-12-08

Review 2.  Ramadan Fasting and NCDs-Example of the Diabetes.

Authors:  Meriem Bencharif; Ibrahim Sersar; Maroua Bentaleb; Fatima Zohra Boutata; Youcef Benabbas
Journal:  Front Nutr       Date:  2022-03-02

3.  Ramadan and Diabetes: What About Non-Fasting Patients with Diabetes?

Authors:  Imane Motaib; Fatima-Zahra Rhmari Tlemçani; Mohamed Khalis; Soukaina Laidi; Saloua Elamari; Asma Chadli
Journal:  Diabetes Metab Syndr Obes       Date:  2022-06-28       Impact factor: 3.249

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.